Login to Your Account



Search

Search results

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Clinic roundup

Gilead Sciences Inc. , of Foster City Calif., said positive top-line results from a phase III trial evaluating Sovaldi (sofosbuvir) in combination with ribavirin for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection in Japan put i ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Clinic roundup

Cardiocell LLC , of San Diego, received investigational new drug approval from the FDA for a phase IIa study using its allogeneic stem cell therapy to treat patients with chronic heart failure (CHF). (BioWorld-Today-2014-04-03) ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments

Clinic Roundup

• Inovio Pharmaceuticals Inc. , of Blue Bell, Pa., said the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in an 18-patient Phase I trial in chronically hepatitis C virus-infec ...

BioWorld Today - Staff - 2013-10-22 00:00 - 0 comments - 0 attachments

Clinic roundup

Galectin Therapeutics Inc. , of Norcross, Ga., said results from the first cohort of its phase I trial showed that GR-MD-02 had an effect on biomarkers that suggests a therapeutic effect on fibrosis, inflammation and cellular injury. (BioWor ...

BioWorld Today - Staff - 2014-04-02 00:00 - 0 comments - 0 attachments

Clinic roundup

Capricor Therapeutics Inc. , of Los Angeles, presented data at the American College of Cardiology 63rd Annual Scientific Session and Expo highlighting positive data from the phase I portion of the company’s ALLSTAR (ALLogeneic heart STem cells to Ach ...

BioWorld Today - Staff - 2014-04-01 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Forest Laboratories Inc ., of New York, and Gedeon Richter Plc , of Budapest, Hungary, reported positive top-line results from a global, randomized, placebo-controlled, fixed-dose, eight-week phase IIb trial evaluating the efficacy and safety of c ...

BioWorld Today - Staff - 2014-04-01 00:00 - 0 comments - 0 attachments

Clinic roundup

Cytokinetics Inc. , of South San Francisco, said it began enrolling the expansion phase of COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure). The double-blind, randomized, placebo-controlled, multicente ...

BioWorld Today - Staff - 2014-03-31 00:00 - 0 comments - 0 attachments

Clinic Roundup

Biogen Idec Inc. , of Weston, Mass., and Swedish Orphan Biovitrum AB , of Stockholm, Sweden, disclosed positive results from A-LONG, a Phase III trial that evaluated a long-lasting clotting factor candidate in people with hemophilia A. (B ...

BioWorld Today - Staff - 2013-12-06 01:00 - 0 comments - 0 attachments